Story of time
Release time:
2020-08-14
Story of Time
■ Jin Xi Factory Zhang Zhijian
Time flies. It seems that it is only a twinkling of an eye that I have been in peak for 20 years. In the past 20 years, I have been working, studying and growing up. Little by little, my experience is the most precious wealth in my life.
In 1996 5 , I was lucky enough to be a member of the peak. I came to Jinguo Cement Plant (later Jinma Cement Plant) and was assigned to the coal mill position in the firing workshop. The production line of Jinguo Cement Plant was the first batch of rotary kilns in Zhejiang Province. At that time, the equipment was still being debugged. On the second day of work, I received the task of adding steel balls to the ball mill. When I saw that pile of steel balls, I was dumbfounded -- it was so heavy, so big, when would it be added? Fortunately, the squad leader had a way to lead us to line up between the mill and the ball pile, and put the steel balls into the machine one by one. After a busy morning, after a hastily finished lunch, everyone moved it again without taking a rest. I was busy until I got off work and finally finished the task. Although everyone was tired, they were all very happy because the trial production was about to ignite. Now I think of the joy of everyone when the ignition was successful, it seems like yesterday.
worked in the cement factory for less than a year, 1997 3 , I was transferred to Jianfeng Kangjie Chemical Co., Ltd., which was later Jiangnan Pharmaceutical Branch. The pharmaceutical factory has a beautiful environment, a high degree of automation in the production line, and it works indoors and has air conditioning, which is incomparable to the cement factory at that time. I made up my mind to work hard and live up to the company's trust.
In 2004 , the factory assigned me to be responsible for the procurement of raw materials. At that time, due to changes in the general environment, drug prices were repeatedly lowered. To control production costs, it was the most direct and important way to purchase raw and auxiliary materials. For this reason, I bargain with the supplier again and again, and try my best to "compress" the price under the premise of ensuring the quality. After hard work, only two raw materials, cefuroxime sodium and azithromycin, saved the purchase cost of ,200 yuan that year. However, good things took a long time. In that year, the company's funds were relatively tight, and sometimes the payment for goods was not timely enough. I tried every possible means to negotiate with the suppliers to win their understanding and support, extend the payment period, and ease the financial pressure in the factory.
In 2005 , the sales volume of cefmenoxime for injection, the main product, was increasing, and the amount of wastewater generated by production was also increasing, far exceeding the treatment capacity of the environmental protection facilities of Jiangnan Factory at that time, so it could only be pulled to Qiubin Pharmaceutical Factory for sewage treatment. Waste water 50 kg is a big barrel. Jiang Guomin and I are carrying, loading and unloading together, every day. The smell of waste water is very strong, it is disgusting to smell, and it is even more uncomfortable to splash on clothes and trousers, and it is even more unbearable in summer. However, we did not complain at all and handled it properly in time to ensure that the factory passed the environmental protection test smoothly. It was also that year that I was named the first gold medal employee by the group company.
In 2006 , I served as the warehouse monitor of Jiangnan Factory. Warehouse management is very trivial. As long as I have time, I will soak in the warehouse to check the storage and quality of various materials, and report problems to relevant departments in time. On one occasion, the azithromycin packing box sent by the printing factory was mistakenly printed as "Qi". After finding the problem, I immediately contacted the manufacturer to return it and redo it. In the management of pharmaceutical production GMP , the warehouse is also a very important link, so together with the warehouse keeper, I did a good job in the acceptance, warehousing, storage and distribution of materials in strict accordance with the specifications, and successfully passed the previous certification inspection. In normal work, if we find that there are raw and auxiliary materials, packaging materials or finished product quality inspection forms that have not arrived, we should also do a good job in linking up with the laboratory work. On one occasion, a batch of cefmenoxime had to be delivered in a hurry, but the quality inspection form was not yet in place. I contacted the central laboratory and learned that it had been opened. I rode my bike to get it back immediately without delaying the delivery.
From Jinguo Cement Company to Kangjie Chemical Company, and from Jiangnan Factory to Jinxi Factory now, along the way, I have witnessed the ups and downs in the process of peak development, tears and laughter, confusion and emotion, but what is more in my heart is a persistence-persisting in studying and striving to improve my business level. Adhere to strict demands on yourself, do every job well in a down-to-earth and conscientious manner. The spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak forever" promotes the continuous development of the peak cause and makes me grow up with the peak.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31